1-9 of 9
Evangelia Antoniou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Analysis of Target and Immune Checkpoint Markers in Pediatric AML

Stephanie Sendker, Jens Gehlen, Tabea Ziedrich, Evangelia Antoniou, Markus Schneider, Nils Von Neuhoff, Dirk Reinhardt, Lina Marie Hoffmeister
Journal: Blood
Blood (2024) 144 (Supplement 1): 4322.
https://doi.org/10.1182/blood-2024-208614
Published: 2024
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia: Results of the AML BFM Study Group

Eva Rettinger, Martin Hutter, Birte Karschen, Evangelia Antoniou, Peter Bader, Rita Beier, Birgit Burkhardt, Ursula Creutzig, Gabriele Escherich, Jan-Henning Klusmann, Peter Lang, Naghmeh Niktoreh, Martin G. Sauer, Stephanie Sendker, Dirk Reinhardt, Katharina Waack
Journal: Blood
Blood (2024) 144 (Supplement 1): 3548.
https://doi.org/10.1182/blood-2024-208311
Published: 2024
Journal Articles

Significance of RT-qPCR-Based Measurable Residual Disease for Optimizing the Treatment of Pediatric Acute Myeloid Leukemia

Evangelia Antoniou, Lina Marie Hoffmeister, Nils Von Neuhoff, Dirk Reinhardt, Markus Schneider, Stephanie Sendker
Journal: Blood
Blood (2024) 144 (Supplement 1): 228.
https://doi.org/10.1182/blood-2024-208718
Published: 2024
Journal Articles

Europeanpediatric Acute Leukemia (EuPAL) Registry

Katarzyna Majstrowicz, Katharina Waack, Evangelia Antoniou, Naghmeh Niktoreh, Gwen Nichols, Laura Di Laurenzio, Michele S. Redell, Todd Cooper, E. Anders Kolb, Sarah K. Tasian, Franco Locatelli, C. Michel Zwaan, Dirk Reinhardt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1496.
https://doi.org/10.1182/blood-2023-189684
Published: 2023
Journal Articles

Characteristics of FLT3 -ITD and Efficacy of Sorafenib Treatment in Pediatric AML: A Report from AML-BFM Study Group

Evangelia Antoniou, Annika Puschnig, Lina Marie Hoffmeister, Amani Awada, Nils Von Neuhoff, Markus Schneider, Dirk Reinhardt, Naghmeh Niktoreh
Journal: Blood
Blood (2023) 142 (Supplement 1): 4217.
https://doi.org/10.1182/blood-2023-187465
Published: 2023
Journal Articles

Treatment Outcomes of Childhood Picalm:MLLT10 + Acute Leukemias: An International Retrospective Study

Catherine Mark, Edward A. Kolb, Bianca F. Goemans, Soheil Meshinchi, Brenda Gibson, Anke K. Bergmann, Christine J. Harrison, Cornelis Jan Pronk, Hélène Lapillonne, Guy Leverger, Evangelia Antoniou, Andishe Attarbaschi, Michael Dworzak, Jan Stary, Daisuke Tomizawa, Monika Lejman, Kjeld Schmiegelow, Henrik Hasle, Brooklyn Joyce, Markus Schneider, Oussama Abla
Journal: Blood
Blood (2022) 140 (Supplement 1): 3403–3404.
https://doi.org/10.1182/blood-2022-156731
Published: 2022
Journal Articles

RUNX1 Mutations Have Distinct Prognostic and Clinical Implication in Pediatric AML: Results of the AML-BFM Study Group

Stephanie Sendker, Markus Schneider, Amani Awada, Eser Orhan, Michael Sendker, Lina Hoffmeister, Evangelia Antoniou, Dirk Reinhardt, Nils Von Neuhoff
Journal: Blood
Blood (2022) 140 (Supplement 1): 9110–9112.
https://doi.org/10.1182/blood-2022-167465
Published: 2022
Journal Articles

Management and Outcome of Hyperleukocytosis As Early Complication in Childhood AML - an AML-BFM Experience

Katharina Waack, Franziska Budeus, Evangelia Antoniou, Dirk Reinhardt
Journal: Blood
Blood (2022) 140 (Supplement 1): 6084–6085.
https://doi.org/10.1182/blood-2022-169455
Published: 2022
Journal Articles

Revision of Complete Remission Criteria in Pediatric AML

Evangelia Antoniou, Annika Puschnig, Katharina Waack, Carolin Augsburg, Christel Katerkamp, Denise Kondryn, Tabea Ziedrich, Nils von Neuhoff, Dirk Reinhardt, Stephanie Sendker
Journal: Blood
Blood (2022) 140 (Supplement 1): 1016–1017.
https://doi.org/10.1182/blood-2022-170648
Published: 2022